Dr. Amy Hellman, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Nebraska College of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 163
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: University of Nebraska College of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NE license 27375
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Nebraska Medical Center Omaha, NE
- Bellevue Medical Center Bellevue, NE
Medical groups
- Unmc Physicians (1,518 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 163
- Services billed
- 597
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 126 | 45 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 115 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 88 | 72 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 65 | 20 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 61 | 21 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | 44 | 17 |
| Established patient office or other outpatient visit, 40-54 minutes | 32 | 29 |
| Injection of chemical for paralysis of nerve muscles on side of face | 30 | 11 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 26 | 12 |
| Established patient office or other outpatient visit, 20-29 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Carbidopa-Levodopa (carbidopa/levodopa) Other prescribers in Omaha, NE | 270 |
| Baclofen Other prescribers in Omaha, NE | 118 |
| Clonazepam Other prescribers in Omaha, NE | 107 |
| Gabapentin Other prescribers in Omaha, NE | 106 |
| Rytary (carbidopa/levodopa) Other prescribers in Omaha, NE | 102 |
| Risperidone Other prescribers in Omaha, NE | 69 |
| Amantadine (amantadine hcl) Other prescribers in Omaha, NE | 58 |
| Propranolol Hcl Other prescribers in Omaha, NE | 48 |
| Primidone Other prescribers in Omaha, NE | 41 |
| Escitalopram Oxalate Other prescribers in Omaha, NE | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $3,293 in research payments for these studies, mostly to the institutions running them.
- Open-label rollover study for continuing valbenazine administration for the treatment of chorea associated with huntington disease
Neurocrine Biosciences, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.